Notices. Notice
645 words·~3 min read·
/register/2014/09/26/2014-22987·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4164-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA-2014-M-0327, FDA-2014-M-0434, FDA-2014-M-0552, FDA-2014-M-0553, FDA-2014-M-0690; FDA-2014-M-0691, FDA-2014-M-0692, FDA-2014-M-0726, FDA-2014-M-0727, FDA-2014-M-0866, and FDA-2014-M-0872] Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is publishing a list of premarket approval applications
(PMAs)that have been approved. This list is intended to inform the public of the availability of safety and effectiveness summaries of approved PMAs through the Internet and the Agency's Division of Dockets Management. ADDRESSES: Submit written requests for copies of summaries of safety and effectiveness data to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. Please cite the appropriate docket number as listed in table 1 when submitting a written request. See the SUPPLEMENTARY INFORMATION section for electronic access to the summaries of safety and effectiveness. FOR FURTHER INFORMATION CONTACT: Nicole Wolanski, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 1650, Silver Spring, MD 20993-0002, 301-796-6570. SUPPLEMENTARY INFORMATION: I. Background In accordance with sections 515(d)(4) and (e)(2) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 360e(d)(4) and (e)(2)), notification of an order approving, denying, or withdrawing approval of a PMA will continue to include a notice of opportunity to request review of the order under section 515(g) of the FD&C Act (21 U.S.C. 360e(g)). The 30-day period for requesting reconsideration of an FDA action under § 10.33(b) (21 CFR 10.33(b)) for notices announcing approval of a PMA begins on the day the notice is placed on the Internet. Section 10.33(b) provides that FDA may, for good cause, extend this 30-day period. Reconsideration of a denial or withdrawal of approval of a PMA may be sought only by the applicant; in these cases, the 30-day period will begin when the applicant is notified by FDA in writing of its decision. The regulations provide that FDA publish a quarterly list of available safety and effectiveness summaries of PMA approvals and denials that were announced during that quarter. The following is a list of approved PMAs for which summaries of safety and effectiveness were placed on the Internet from April 1, 2014, through June 30, 2014. There were no denial actions during this period. The list provides the manufacturer's name, the product's generic name or the trade name, and the approval date. Table 1—List of Safety and Effectiveness Summaries for Approved PMAs Made Available From April 1, 2014, Through June 30, 2014 PMA No., Docket No. Applicant Trade name Approval date P130016, FDA-2014-M-0327 Cochlear Americas Nucleus® Hybrid TM L24 Cochlear Implant System March 20, 2014. P120020, FDA-2014-M-0434 Abbott Vascular (IDEV Technologies, Inc.) SUPERA® Peripheral Stent System March 28, 2014. P010015/S205, FDA-2014-M-0553 Medtronic, Inc Cardiac Resynchronization Therapy Pacemaker (CRT-P) Devices April 10, 2014. P010031/S381, FDA-2014-M-0553 Medtronic, Inc Cardiac Resynchronization Therapy Defibrillator (CRT-D) Devices April 10, 2014. P100020/S008, FDA-2014-M-0552 Roche Molecular Systems, Inc cobas® HPV Test April 24, 2014. P130008, FDA-2014-M-0690 Inspire Medical Systems, Inc Inspire Upper Airway Stimulation
(UAS)system April 30, 2014. P110005, FDA-2014-M-0691 IBSA Institut Biochimique SA Gel-Syn TM Sinovial (Sodium Hyaluronate 0.8%) May 9, 2014. P110041, FDA-2014-M-0692 Siemens Healthcare Diagnostics ADVIA Centaur® HBsAgII, ADVIA Centaur® HBsAg Confirmatory and ADVIA Centaur® HBsAg Quality Control Material May 16, 2014. P110027, FDA-2014-M-0726 QIAGEN Manchester Ltd therascreen® KRAS RGQ PCR Kit May 23, 2014. P100045, FDA-2014-M-0727 CardioMEMS, Inc CardioMEMS TM HF System May 28, 2014. P130027, FDA-2014-M-0866 QIAGEN, Inc artus® CMV RGQ MDx Kit June 2, 2014. P040024/S072, FDA-2014-M-0872 Valeant Pharmaceuticals North America LLC/Medicis Restylane Silk Injectable Gel June 13, 2014. II. Electronic Access Persons with access to the Internet may obtain the documents at *http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/PMAApprovals/default.htm.* Dated: September 23, 2014 Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2014-22987 Filed 9-25-14; 8:45 am]
Connectionstraces to 2
Traces to 2 documents
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources